Riggs J E, Stowers R S, Mosier D E
Medical Biology Institute, Division of Immunology, La Jolla, California 92037.
J Exp Med. 1990 Aug 1;172(2):475-85. doi: 10.1084/jem.172.2.475.
We have studied potential regulatory interactions between mature B lymphocyte populations by analysis of C.B-17 severe combined immunodeficient (SCID) mice reconstituted simultaneously with immunoglobulin allotype-congenic mixtures of spleen (SP) and peritoneal cavity (PerC) B cells. We have previously shown that the independent transfer of B cells from these sources leads to the long-term survival of donor B cells and reconstitution of immunoglobulin levels in SCID mice (Riggs, J.E., D.L. Robertson, R.S. Stowers, and D.E. Mosier, manuscript submitted for publication). SP and PerC B cells differ in numerous respects, with the PerC having higher proportions of large, activated B cells that express the IgM greater than IgD phenotype and greater numbers of CD5 B cells. The injection of equal numbers of B cells from SP and PerC into SCID recipients (e.g., BALB/c SP + C.B-17 Per C----SCID) has led to the following observations: (a) serum IgM allotypes in B cell chimeras revealed strict dominance by the allotype contributed by the PerC B cells; (b) this dominance was not due to regulatory T cells; (c) B cells of the unexpressed (i.e., SP) allotype were present in the chimera in the spleen but not the peritoneal cavity; and (d) immunization with TI and TD antigens failed to elicit the SP IgM allotype, whereas secondary TD antigen immunization elicited low levels of the SP IgG2a allotype. Additional experiments demonstrated concurrent expression of IgM allotypes derived from both SP and PerC B cells in recipients that: (a) received a 10-fold excess of SP B cells; (b) received SP B cells before PerC B cell transfer; or (c) received SP B cells intravenously and PerC B cells intraperitoneally. We conclude that the establishment of IgM synthesis by PerC B cells leads to a feedback inhibition of subsequent IgM synthesis by SP B cells, and that the frequency of B cells that can lead to this effect is substantially higher in peritoneal cavity than in spleen. These data provide further confirmation of regulatory interactions between B cells in the absence of T lymphocytes, but confound the interpretation of experiments supporting the existence of a separate CD5+ B cell lineage.
我们通过分析同时用脾脏(SP)和腹腔(PerC)B细胞的免疫球蛋白同种异型同基因混合物重建的C.B-17重度联合免疫缺陷(SCID)小鼠,研究了成熟B淋巴细胞群体之间潜在的调节相互作用。我们之前已经表明,来自这些来源的B细胞的独立转移会导致供体B细胞的长期存活以及SCID小鼠中免疫球蛋白水平的重建(Riggs,J.E.,D.L. Robertson,R.S. Stowers和D.E. Mosier,已提交发表的手稿)。SP和PerC B细胞在许多方面存在差异,PerC中具有更高比例的表达IgM大于IgD表型的大的、活化的B细胞以及更多数量的CD5 B细胞。将等量的来自SP和PerC的B细胞注射到SCID受体中(例如,BALB/c SP + C.B-17 Per C----SCID)导致了以下观察结果:(a)B细胞嵌合体中的血清IgM同种异型显示出由PerC B细胞贡献的同种异型的严格优势;(b)这种优势不是由于调节性T细胞;(c)未表达(即SP)同种异型的B细胞存在于嵌合体的脾脏中而非腹腔中;(d)用TI和TD抗原免疫未能引发SP IgM同种异型,而二次TD抗原免疫引发了低水平的SP IgG2a同种异型。额外的实验表明,在以下受体中同时表达源自SP和PerC B细胞的IgM同种异型:(a)接受了10倍过量的SP B细胞;(b)在PerC B细胞转移之前接受了SP B细胞;或(c)静脉内接受SP B细胞并腹腔内接受PerC B细胞。我们得出结论,PerC B细胞建立IgM合成会导致对SP B细胞随后的IgM合成的反馈抑制,并且能够导致这种效应的B细胞频率在腹腔中比在脾脏中高得多。这些数据进一步证实了在没有T淋巴细胞的情况下B细胞之间的调节相互作用,但混淆了支持存在单独的CD5 + B细胞谱系的实验的解释。